Insider Transactions in Q1 2026 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2026
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,400
-10.52%
|
$4,804,800
$132.71 P/Share
|
|
Jan 16
2026
|
Kyle Gano Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,400
+8.88%
|
$1,274,000
$35.99 P/Share
|
|
Jan 08
2026
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,349
+6.68%
|
$117,215
$35.99 P/Share
|